94 related articles for article (PubMed ID: 25406622)
1. The regulatory network of proneural glioma in tumor progression.
Starke RM; Komotar RJ; Connolly ES
Neurosurgery; 2014 Dec; 75(6):N15-6. PubMed ID: 25406622
[No Abstract] [Full Text] [Related]
2. [A hypothesis: neural glial cells, neural stem cells and tumor stem cells transform each other depending on the micro-ecological environment].
Huang Q; DU ZW
Zhonghua Zhong Liu Za Zhi; 2010 Jan; 32(1):76-8. PubMed ID: 20211077
[No Abstract] [Full Text] [Related]
3. A novel drug conjugate, NEO212, targeting proneural and mesenchymal subtypes of patient-derived glioma cancer stem cells.
Jhaveri N; Agasse F; Armstrong D; Peng L; Commins D; Wang W; Rosenstein-Sisson R; Vaikari VP; Santiago SV; Santos T; Chen L; Schönthal AH; Chen TC; Hofman FM
Cancer Lett; 2016 Feb; 371(2):240-50. PubMed ID: 26683773
[TBL] [Abstract][Full Text] [Related]
4. Mosaic analysis with double markers reveals tumor cell of origin in glioma.
Liu C; Sage JC; Miller MR; Verhaak RG; Hippenmeyer S; Vogel H; Foreman O; Bronson RT; Nishiyama A; Luo L; Zong H
Cell; 2011 Jul; 146(2):209-21. PubMed ID: 21737130
[TBL] [Abstract][Full Text] [Related]
5. Cell of origin for malignant gliomas and its implication in therapeutic development.
Zong H; Parada LF; Baker SJ
Cold Spring Harb Perspect Biol; 2015 Jan; 7(5):. PubMed ID: 25635044
[TBL] [Abstract][Full Text] [Related]
6. Culture conditions tailored to the cell of origin are critical for maintaining native properties and tumorigenicity of glioma cells.
Ledur PF; Liu C; He H; Harris AR; Minussi DC; Zhou HY; Shaffrey ME; Asthagiri A; Lopes MB; Schiff D; Lu YC; Mandell JW; Lenz G; Zong H
Neuro Oncol; 2016 Oct; 18(10):1413-24. PubMed ID: 27106408
[TBL] [Abstract][Full Text] [Related]
7. Neural stem cells preferentially migrate to glioma stem cells and reduce their stemness phenotypes.
Zhang S; Xie R; Zhao T; Yang X; Han L; Ye F; Lei T; Wan F
Int J Oncol; 2014 Nov; 45(5):1989-96. PubMed ID: 25176161
[TBL] [Abstract][Full Text] [Related]
8. Qki deficiency maintains stemness of glioma stem cells in suboptimal environment by downregulating endolysosomal degradation.
Shingu T; Ho AL; Yuan L; Zhou X; Dai C; Zheng S; Wang Q; Zhong Y; Chang Q; Horner JW; Liebelt BD; Yao Y; Hu B; Chen Y; Fuller GN; Verhaak RG; Heimberger AB; Hu J
Nat Genet; 2017 Jan; 49(1):75-86. PubMed ID: 27841882
[TBL] [Abstract][Full Text] [Related]
9. Heterogeneous cellular origins for glioma in murine model.
Jandial R; Chen MY
Neurosurgery; 2013 Apr; 72(4):N20. PubMed ID: 23511833
[No Abstract] [Full Text] [Related]
10. Paired related homeobox 1 transactivates dopamine D2 receptor to maintain propagation and tumorigenicity of glioma-initiating cells.
Li Y; Wang W; Wang F; Wu Q; Li W; Zhong X; Tian K; Zeng T; Gao L; Liu Y; Li S; Jiang X; Du G; Zhou Y
J Mol Cell Biol; 2017 Aug; 9(4):302-314. PubMed ID: 28486630
[TBL] [Abstract][Full Text] [Related]
11. Familial mixed oligodendrocytic-astrocytic gliomas.
Leblanc R; Lozano A; Robitaille Y
Neurosurgery; 1986 Apr; 18(4):480-2. PubMed ID: 3703224
[TBL] [Abstract][Full Text] [Related]
12. PDGF Engages an E2F-USP1 Signaling Pathway to Support ID2-Mediated Survival of Proneural Glioma Cells.
Rahme GJ; Zhang Z; Young AL; Cheng C; Bivona EJ; Fiering SN; Hitoshi Y; Israel MA
Cancer Res; 2016 May; 76(10):2964-76. PubMed ID: 26951930
[TBL] [Abstract][Full Text] [Related]
13. A Tumor Suppressor Function for Notch Signaling in Forebrain Tumor Subtypes.
Giachino C; Boulay JL; Ivanek R; Alvarado A; Tostado C; Lugert S; Tchorz J; Coban M; Mariani L; Bettler B; Lathia J; Frank S; Pfister S; Kool M; Taylor V
Cancer Cell; 2015 Dec; 28(6):730-742. PubMed ID: 26669487
[TBL] [Abstract][Full Text] [Related]
14. Expression analysis of genes involved in brain tumor progression driven by retroviral insertional mutagenesis in mice.
Johansson FK; Göransson H; Westermark B
Oncogene; 2005 Jun; 24(24):3896-905. PubMed ID: 15750623
[TBL] [Abstract][Full Text] [Related]
15. Oligodendrocyte progenitor cells promote neovascularization in glioma by disrupting the blood-brain barrier.
Huang Y; Hoffman C; Rajappa P; Kim JH; Hu W; Huse J; Tang Z; Li X; Weksler B; Bromberg J; Lyden DC; Greenfield JP
Cancer Res; 2014 Feb; 74(4):1011-21. PubMed ID: 24371228
[TBL] [Abstract][Full Text] [Related]
16. Endothelium-induced three-dimensional invasion of heterogeneous glioma initiating cells in a microfluidic coculture platform.
Chonan Y; Taki S; Sampetrean O; Saya H; Sudo R
Integr Biol (Camb); 2017 Sep; 9(9):762-773. PubMed ID: 28752870
[TBL] [Abstract][Full Text] [Related]
17. The transcriptional regulatory network of proneural glioma determines the genetic alterations selected during tumor progression.
Sonabend AM; Bansal M; Guarnieri P; Lei L; Amendolara B; Soderquist C; Leung R; Yun J; Kennedy B; Sisti J; Bruce S; Bruce R; Shakya R; Ludwig T; Rosenfeld S; Sims PA; Bruce JN; Califano A; Canoll P
Cancer Res; 2014 Mar; 74(5):1440-1451. PubMed ID: 24390738
[TBL] [Abstract][Full Text] [Related]
18. miRNAs targeting in glioma stem cell maintenance.
Kerstetter-Fogle AE
Regen Med; 2013 Nov; 8(6):696-7. PubMed ID: 24308042
[No Abstract] [Full Text] [Related]
19. New advances of microRNAs in glioma stem cells, with special emphasis on aberrant methylation of microRNAs.
Zhao B; Bian EB; Li J; Li J
J Cell Physiol; 2014 Sep; 229(9):1141-7. PubMed ID: 24374932
[TBL] [Abstract][Full Text] [Related]
20. Glioma stem cells are more aggressive in recurrent tumors with malignant progression than in the primary tumor, and both can be maintained long-term in vitro.
Huang Q; Zhang QB; Dong J; Wu YY; Shen YT; Zhao YD; Zhu YD; Diao Y; Wang AD; Lan Q
BMC Cancer; 2008 Oct; 8():304. PubMed ID: 18940013
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
